Literature DB >> 32337200

CD56+ lymphoepithelioma-like carcinoma of the lung: A case report and literature review.

Lin Yang1, Hua Liang2, Li Liu1, Lei Guo1, Jian-Ming Ying1, Su-Sheng Shi1, Xing-Sheng Hu3.   

Abstract

BACKGROUND: Lymphoepithelioma-like carcinoma (LELC) is a non-keratinizing carcinoma with rich lymphocytic infiltration, which primarily originates from the nasopharynx. Primary lung LELC is a type of lung cancer with a relatively low incidence. Herein, we report a rare case of lung LELC with expression of CD56. We also performed a literature review to summarize the epidemiological, clinical, and prognostic features of this disease. CASE
SUMMARY: A 51-year-old man was admitted to Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College due to cough and chest pain lasting > 2 mo and 1 wk, respectively. Positron emission tomography-computed tomography and magnetic resonance imaging examinations revealed the presence of a mass in the right upper lobe with enlargement of lymph nodes and multiple bone metastases. According to the results of bronchoscopy and cervical lymph node biopsy, a diagnosis of lung LELC with CD56-positive staining (CD56+ lung LELC) was made. In the literature, 458 cases of lung LELC have been reported. However, only one other case of CD56+ lung LELC has been reported thus far.
CONCLUSION: The mechanism and potential role of CD56 expression in CD56+ lung LELC require further investigation. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  CD56; Case report; EBER; Literature review; Lung; Lymphoepithelioma-like carcinoma

Year:  2020        PMID: 32337200      PMCID: PMC7176613          DOI: 10.12998/wjcc.v8.i7.1257

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  33 in total

Review 1.  Lymphoepithelioma-like carcinoma of the lung with a better prognosis. A clinicopathologic study of 32 cases.

Authors:  A J Han; M Xiong; Y Y Gu; S X Lin; M Xiong
Journal:  Am J Clin Pathol       Date:  2001-06       Impact factor: 2.493

2.  Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: a case report and focused review of literature.

Authors:  Chul Kim; Arun Rajan; Pedro A DeBrito; Giuseppe Giaccone
Journal:  Transl Lung Cancer Res       Date:  2016-12

3.  Lymphoepithelioma-like Carcinoma of the Breast: A Case Report.

Authors:  Ömer Erdinç Top; Enver Vardar; Ayşe Yağcı; Senem Deniz; Rafet Öztürk; Baha Zengel
Journal:  J Breast Health       Date:  2014-07-01

4.  TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.

Authors:  Giulio Rossi; Alessandro Marchioni; Marina Milani; Rosa Scotti; Moira Foroni; AnnaMaria Cesinaro; Lucio Longo; Mario Migaldi; Alberto Cavazza
Journal:  Am J Clin Pathol       Date:  2004-12       Impact factor: 2.493

5.  Lymphoepithelioma-like carcinoma of the lung.

Authors:  A E Butler; T V Colby; L Weiss; C Lombard
Journal:  Am J Surg Pathol       Date:  1989-08       Impact factor: 6.394

6.  Lymphoepithelioma-like carcinoma of the lung: experience with ten cases.

Authors:  J C Ho; W K Lam; M P Wong; M K Wong; G C Ooi; M S Ip; M Chan-Yeung; K W Tsang
Journal:  Int J Tuberc Lung Dis       Date:  2004-07       Impact factor: 2.373

7.  Computed tomography characteristics of primary pulmonary lymphoepithelioma-like carcinoma in 41 patients.

Authors:  Huali Ma; Yaopan Wu; Yongbin Lin; Qingqing Cai; Guowei Ma; Ying Liang
Journal:  Eur J Radiol       Date:  2013-03-05       Impact factor: 3.528

8.  Primary pulmonary lymphoepithelioma-like carcinoma initially diagnosed as squamous metaplasia: A case report and literature review.

Authors:  Yasha Liang; Cheng Shen; Guowei Che; Fengming Luo
Journal:  Oncol Lett       Date:  2015-02-17       Impact factor: 2.967

9.  PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival.

Authors:  Wenfeng Fang; Shaodong Hong; Nan Chen; Xiaobo He; Jianhua Zhan; Tao Qin; Ting Zhou; Zhihuang Hu; Yuxiang Ma; Yuanyuan Zhao; Ying Tian; Yunpeng Yang; Cong Xue; Yanna Tang; Yan Huang; Hongyun Zhao; Li Zhang
Journal:  Oncotarget       Date:  2015-10-20

10.  [Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia].

Authors:  J Wu; A D Lu; L P Zhang; Y X Zuo; Y P Jia
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.